ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Glaxosmithkline Intellectual Property (No.5) Limited

Glaxosmithkline Intellectual Property (No.5) Limited is a liquidation company incorporated on 23 April 2019 with the registered office located in Liverpool, Merseyside. Glaxosmithkline Intellectual Property (No.5) Limited was registered 6 years ago.
Status
Liquidation
In voluntary liquidation since 1 month ago
Company No
11959399
Private limited company
Age
6 years
Incorporated 23 April 2019
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 12 October 2024 (10 months ago)
Next confirmation dated 12 October 2025
Due by 26 October 2025 (1 month remaining)
No changes occurred since incorporation
Accounts
Due Soon
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Audit Exemption Subsidiary
Next accounts for period 31 December 2024
Due by 30 September 2025 (23 days remaining)
Contact
Address
C/O Bdo Llp 5 Temple Square
Temple Street
Liverpool
L2 5RH
Address changed on 22 Jul 2025 (1 month ago)
Previous address was Gsk Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY United Kingdom
Telephone
Unreported
Email
Unreported
Website
People
Officers
12
Shareholders
1
Controllers (PSC)
1
Director • Director • Turkish • Lives in Germany • Born in Oct 1971
Director • Director • VP Oncology, R&D Finance • British • Lives in UK • Born in Oct 1977
Director • British • Lives in UK • Born in Jun 1977
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Glaxosmithkline Intellectual Property Management Limited
The Wellcome Foundation Limited, Jill Dawn Anderson, and 7 more are mutual people.
Active
Glaxosmithkline Intellectual Property (No.3) Limited
The Wellcome Foundation Limited, Jill Dawn Anderson, and 7 more are mutual people.
Active
Glaxosmithkline Intellectual Property (No.4) Limited
The Wellcome Foundation Limited, Jill Dawn Anderson, and 7 more are mutual people.
Active
Glaxosmithkline Intellectual Property Limited
Jill Dawn Anderson, Graham Paul Rivers, and 6 more are mutual people.
Active
Glaxosmithkline Intellectual Property Development Limited
Jill Dawn Anderson, Graham Paul Rivers, and 6 more are mutual people.
Active
Glaxosmithkline Intellectual Property (No.2) Limited
Jill Dawn Anderson, Graham Paul Rivers, and 6 more are mutual people.
Active
Glaxosmithkline Intellectual Property Holdings Limited
Jill Dawn Anderson, Graham Paul Rivers, and 6 more are mutual people.
Active
Glaxo Wellcome UK Limited
Jill Dawn Anderson, Graham Paul Rivers, and 5 more are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2019–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£23.73M
Increased by £6.31M (+36%)
Total Liabilities
-£95.57M
Increased by £10.5M (+12%)
Net Assets
-£71.84M
Decreased by £4.18M (+6%)
Debt Ratio (%)
403%
Decreased by 85.73% (-18%)
Latest Activity
Declaration of Solvency
1 Month Ago on 23 Jul 2025
Registered Address Changed
1 Month Ago on 22 Jul 2025
Voluntary Liquidator Appointed
1 Month Ago on 22 Jul 2025
Jemma-Louise Reynolds Resigned
5 Months Ago on 31 Mar 2025
Adam Walker Resigned
5 Months Ago on 31 Mar 2025
Cristina Barcelo Iglesias Resigned
5 Months Ago on 31 Mar 2025
the Wellcome Foundation Limited Resigned
5 Months Ago on 31 Mar 2025
Demet Gurunlu Russ Resigned
5 Months Ago on 31 Mar 2025
Confirmation Submitted
10 Months Ago on 14 Oct 2024
Mrs Cristina Barcelo Iglesias Appointed
11 Months Ago on 23 Sep 2024
Get Credit Report
Discover Glaxosmithkline Intellectual Property (No.5) Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Declaration of solvency
Submitted on 23 Jul 2025
Appointment of a voluntary liquidator
Submitted on 22 Jul 2025
Resolutions
Submitted on 22 Jul 2025
Registered office address changed from Gsk Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY United Kingdom to C/O Bdo Llp 5 Temple Square Temple Street Liverpool L2 5RH on 22 July 2025
Submitted on 22 Jul 2025
Statement of capital on 3 June 2025
Submitted on 3 Jun 2025
Statement by Directors
Submitted on 3 Jun 2025
Solvency Statement dated 21/05/25
Submitted on 2 Jun 2025
Resolutions
Submitted on 2 Jun 2025
Termination of appointment of Jemma-Louise Reynolds as a director on 31 March 2025
Submitted on 7 Apr 2025
Statement of capital following an allotment of shares on 1 April 2025
Submitted on 7 Apr 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year